Monday OCTOBER 19, 2015

8.30 – 16.00

Forum Atidim Ramat Hachayal







In this advanced one-day program, you will have a unique opportunity to receive practical drafting and prosecution tips from two highly experienced European patent attorneys. The topics covered will be inventions in the field high tech and information technology (IT), pharma and biotech, as well as the use of PPH before the European Patent Office (EPO) for these inventions.   YOU CAN ATTEND A HALF DAY IN YOUR AREA OF TECHNOLOGY IF YOU WISH.


Who Should Attend

This program is suitable for private and corporate practitioners with patent experience, especially in the field of high tech and information technology, pharma and biotech, who wish to strengthen their knowledge of patent procurement before the EPO. While the notions shared during the course will be based on the latest EPO case law and guidelines, the course will have a very practical and interactive approach.


Course Program


  • 08.30 – 09.00 Continental Breakfast and gathering


  • 09.00 – 11.00 drafting and prosecuting IT patent applications before the EPO


  • 11.00-11.30 coffee break


  • 11.30-12.30 PPH before the EPO


  • 12.30 – 13.30 Lunch Break


  • 13.30 – 15.30 drafting and prosecuting pharma and biotech patent applications before the EPO




Micaela Modiano and Alessandro Sanchini are European patent attorneys, and partners at Modiano & Partners, one of the leading IP firms in Europe. 


Alessandro is a software engineer specializing in drafting, prosecution and litigation of IT inventions. He was involved in major international litigations, assisting RIM, Nokia, NEC and Samsung. Prior to joining Modiano & Partners, he worked for a few years as a computer developer and software architect.










Micaela is an organic chemist specializing in drafting, prosecution and litigation of pharma and biotech inventions. She received her education from Harvard University, the University of London and the University of Strasbourg. She is a member of the council of epi (the European patent attorneys’ association) and of the EPPC (the epi committee advising the EPO on legislative issues).